About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in Chicago | 115 Studies

Clinical Trials COVID-19Chicago

COVID-19 Clinical Trials in Chicago

Find 115 clinical trials for covid-19 near Chicago, Illinois. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 115 trials

TerminatedReparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired PneumoniaPrimary objective: \- To compare the efficacy of reparixin vs. placebo in the proportion of patients dead or requiring IMV (or ECMO) by Day 28.NCT05254990·Tucson, Arizona and 73 others

COVID-19 Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedClinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole BloodProspective, multi-center, observational, blinded clinical trial to compare a new point of care (POC) SARS-CoV-2 IgG antibody test to a reference SARS-CoV-2 PCR test using…NCT04699903·Colton, California and 2 others

CompletedA Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19The purpose of this study is to characterize the safety and immunogenicity of AZD9838 and AZD6563 when administered as a single dose vaccination against SARS-CoV-2 in adults.NCT06147063·Long Beach, California and 4 others

CompletedPhase 3 Adolescent Study for SARS-CoV-2 rS Variant VaccinesThis study is a large-scale investigation (Phase 3) into a new booster shot designed specifically for teenagers.NCT05973006·Davie, Florida and 19 others

CompletedAdaptive COVID-19 Treatment Trial 2 (ACTT-2)ACTT-2 will evaluate the combination of baricitinib and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized.NCT04401579·Birmingham, Alabama and 70 others

CompletedCharacterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19The purpose of this study is to learn more about infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).NCT04403880·Birmingham, Alabama and 52 others

Active not recruitingStudy of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in AdultsThis Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity and safety profile.NCT04636697·Birmingham, Alabama and 90 others

TerminatedPBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19.NCT05543707·Mesa, Arizona and 53 others

TerminatedAssessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)The purpose of this study is to evaluate the efficacy and safety of ruxolitinib in the treatment of participants with COVID-19-associated Acute Respiratory Distress Syndrome…NCT04377620·Scottsdale, Arizona and 35 others

CompletedA Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of AgeThis study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concerns (VOCs) in…NCT05436834·Bessemer, Alabama and 73 others

CompletedHealthcare Worker Exposure Response and Outcomes of HydroxychloroquineThis is a double blind, placebo controlled study in approximately 2,000 health care workers at risk for being exposed to COVID-19.NCT04334148·Aurora, Colorado and 33 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05894577·Chandler, Arizona and 108 others

TerminatedCOVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80A multi-center adaptive randomized placebo-controlled platform trial evaluating the efficacy and safety of anti-thrombotic strategies in COVID-19 adults not requiring…NCT04498273·Los Angeles, California and 70 others

CompletedImmune Response to SARS-CoV-2/COVID-19 Vaccination in SarcoidosisPeople with sarcoidosis, particularly those with significant lung and/or cardiac involvement, who become infected with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)…NCT05089565·Chicago, Illinois

CompletedRECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID SymptomsThis study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be…NCT05595369·Birmingham, Alabama and 68 others

RecruitingA Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 InfectionThe study team proposes to evaluate the efficacy of Astepro® 0.15% nasal spray in treating SARS-CoV-2 infection in adults through a pilot and feasibility clinical trial at the…NCT06008860·Chicago, Illinois

RecruitingPhase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT StudyThis study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.NCT03808922·Duarte, California and 27 others

TerminatedNasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)The purpose of this study is to evaluate the safety and effectiveness of NasoVAX in preventing worsening of symptoms and hospitalization in patients with early COVID-19.NCT04442230·Miami, Florida and 6 others

CompletedStudy of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)The purpose of the study is to assess if the study medication (molnupiravir, MK-4482) will prevent symptomatic coronavirus disease 2019 (COVID-19) in adults who live with someone…NCT04939428·Birmingham, Alabama and 225 others

CompletedEPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19The purpose of this study is to determine whether PF-07321332/ritonavir is safe and effective for the treatment of adults who are ill with COVID-19 and do not need to be in the…NCT04960202·Pelham, Alabama and 200 others

PreviousPage 3 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia